Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Giuliani

Showing results (51-60 of 141) with videos related to

Pageof 15
Sort By:
Revue Medicale Suisse|October 14, 2008
[Mental retardation and psychiatry]F Grasset, J Favrod, F Giuliani, et al.
Journal of Biological Regulators and Homeostatic Agents|September 18, 2010
Circadian rhythmicity of lymphocyte subpopulations and relationship with neuro-endocrine systemG Mazzoccoli, A De Cata, A Greco, et al.
Tumori|July 1, 1977
Tumors and dental and ocular abnormalities after treatment of infant rats with adriamycinA M Casazza, O Bellini, F Formelli, et al.
Molecular Pharmacology|July 11, 1998
Sensitivity to cisplatin and platinum-containing compounds of Schizosaccharomyces pombe rad mutantsP Perego, F Zunino, N Carenini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2007
Cetuximab in squamous cell head and neck carcinomasV Gebbia, F Giuliani, V M Valori, et al.
Cancer Treatment Reviews|December 7, 2010
Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic targetF De Vita, F Giuliani, N Silvestris, et al.
Journal of Biological Regulators and Homeostatic Agents|November 20, 2012
Update of adjustable fortification regimen for preterm infants: a new protocolS Arslanoglu, E Bertino, A Coscia, et al.
Neurology|July 20, 2007
Experimental models of neuroprotection relevant to multiple sclerosisV W Yong, F Giuliani, M Xue, et al.
La Clinica Terapeutica|March 3, 1999
A phase II trial of etoposide, folinic acid, fluorouracil and epirubicin in advanced pancreatic carcinomaE Maiello, V Gebbia, F Giuliani, et al.
Minerva Chirurgica|January 1, 1992
[The pre- and postoperative and follow-up use of the tumor markers MCA, CA-125 and CA-19-9]C Zanon, P Alluminio, V Margarita, et al.
Pageof 15

Showing results (51-60 of 141) with videos related to

Sort By:
Pageof 15
Revue Medicale Suisse|October 14, 2008
[Mental retardation and psychiatry]F Grasset, J Favrod, F Giuliani, et al.
Journal of Biological Regulators and Homeostatic Agents|September 18, 2010
Circadian rhythmicity of lymphocyte subpopulations and relationship with neuro-endocrine systemG Mazzoccoli, A De Cata, A Greco, et al.
Tumori|July 1, 1977
Tumors and dental and ocular abnormalities after treatment of infant rats with adriamycinA M Casazza, O Bellini, F Formelli, et al.
Molecular Pharmacology|July 11, 1998
Sensitivity to cisplatin and platinum-containing compounds of Schizosaccharomyces pombe rad mutantsP Perego, F Zunino, N Carenini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2007
Cetuximab in squamous cell head and neck carcinomasV Gebbia, F Giuliani, V M Valori, et al.
Cancer Treatment Reviews|December 7, 2010
Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic targetF De Vita, F Giuliani, N Silvestris, et al.
Journal of Biological Regulators and Homeostatic Agents|November 20, 2012
Update of adjustable fortification regimen for preterm infants: a new protocolS Arslanoglu, E Bertino, A Coscia, et al.
Neurology|July 20, 2007
Experimental models of neuroprotection relevant to multiple sclerosisV W Yong, F Giuliani, M Xue, et al.
La Clinica Terapeutica|March 3, 1999
A phase II trial of etoposide, folinic acid, fluorouracil and epirubicin in advanced pancreatic carcinomaE Maiello, V Gebbia, F Giuliani, et al.
Minerva Chirurgica|January 1, 1992
[The pre- and postoperative and follow-up use of the tumor markers MCA, CA-125 and CA-19-9]C Zanon, P Alluminio, V Margarita, et al.
Pageof 15